Omkar Speciality Chemicals Ltd

Omkar Spl.Chem. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Omkar Speciality Chemicals Ltd

₹ 3.41 -4.75%
28 Apr 2026
omkarchemicals.com BSE: 533317 NSE: OMKARCHEM
About

Incorporated in 1993, Omkar Specialty Chemicals Ltd is a global specialty chemicals company.[1]

Key Points

Business Overview:[1][2]
a) OSCL manufactures specialty chemicals and pharma intermediates like organic and inorganic chemicals, and organo-inorganic intermediates.
b) The Inorganic Intermediates include Molybdenum derivatives, Selenium derivatives, Iodine derivatives, Cobalt derivatives, Bismuth & Tungsten derivatives, and organic intermediates include Tartaric acid derivatives and other intermediates.
c) The pharmaceutical industry remains the major end user segment of the company, accounting for nearly 70-75% of its revenues, with poultry, glass, and water treatment being the other major end user segments.

Website BSE NSE - BZ
  • Market Cap ₹ 7.02 Cr.
  • Current Price ₹ 3.41
  • High / Low ₹ 8.10 / 3.35
  • Stock P/E
  • Book Value ₹ 9.41
  • Dividend Yield 0.00 %
  • ROCE %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.36 times its book value

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -67.0% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Jun 2025 Sep 2025 Dec 2025
12.79 5.14 16.86 12.16 10.97 7.36 4.23 6.34 5.05 3.74 0.01 0.08 0.01
14.83 4.86 13.80 9.20 10.78 7.76 6.55 6.21 8.16 4.69 0.20 0.37 0.11
Operating Profit -2.04 0.28 3.06 2.96 0.19 -0.40 -2.32 0.13 -3.11 -0.95 -0.19 -0.29 -0.10
OPM % -15.95% 5.45% 18.15% 24.34% 1.73% -5.43% -54.85% 2.05% -61.58% -25.40% -1,900.00% -362.50% -1,000.00%
0.08 1.01 0.07 0.55 4.16 0.02 0.72 0.01 0.21 0.12 0.00 0.00 0.00
Interest 1.08 1.25 1.59 1.52 1.21 1.43 1.49 1.57 1.58 1.69 0.00 0.00 0.00
Depreciation 1.25 1.03 0.98 0.98 0.57 0.47 0.47 0.40 0.44 0.39 0.22 0.23 0.23
Profit before tax -4.29 -0.99 0.56 1.01 2.57 -2.28 -3.56 -1.83 -4.92 -2.91 -0.41 -0.52 -0.33
Tax % 26.11% 34.34% 71.43% 39.60% -0.39% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-5.42 -1.34 0.16 0.61 2.58 -2.28 -3.56 -1.84 -4.92 -2.90 -0.41 -0.52 -0.33
EPS in Rs -2.63 -0.65 0.08 0.30 1.25 -1.11 -1.73 -0.89 -2.39 -1.41 -0.20 -0.25 -0.16
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2025
166.95 201.53 209.62 193.32 319.06 316.74 197.64 42.65 56.61 44.97 22.98 0.22
133.75 165.20 176.72 164.38 273.64 359.84 241.00 43.95 56.86 37.59 28.69 0.62
Operating Profit 33.20 36.33 32.90 28.94 45.42 -43.10 -43.36 -1.30 -0.25 7.38 -5.71 -0.40
OPM % 19.89% 18.03% 15.70% 14.97% 14.24% -13.61% -21.94% -3.05% -0.44% 16.41% -24.85% -181.82%
3.70 5.79 5.68 4.91 8.75 -60.96 -48.90 12.39 0.45 4.90 0.96 0.00
Interest 8.10 7.43 11.75 11.43 16.52 21.83 26.13 14.62 4.93 5.57 6.07 0.00
Depreciation 5.62 5.68 6.10 1.97 4.28 10.90 8.16 7.99 6.59 3.56 1.79 0.91
Profit before tax 23.18 29.01 20.73 20.45 33.37 -136.79 -126.55 -11.52 -11.32 3.15 -12.61 -1.31
Tax % 29.03% 28.30% 29.57% 12.27% 33.44% -20.05% -17.84% 46.44% 29.33% 36.19% 0.00% 0.00%
16.45 20.80 14.60 17.93 22.21 -109.36 -103.97 -16.87 -14.63 2.01 -12.61 -1.30
EPS in Rs 8.39 10.61 7.45 8.70 10.78 -53.09 -50.47 -8.19 -7.10 0.98 -6.12 -0.63
Dividend Payout % 14.92% 14.16% 20.17% 17.22% 13.90% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -49%
5 Years: -67%
3 Years: -79%
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: 14%
3 Years: 24%
TTM: %
Stock Price CAGR
10 Years: -27%
5 Years: -18%
3 Years: -25%
1 Year: -54%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2026
Equity Capital 19.63 19.63 19.63 20.58 20.58 20.58 20.58 20.58 20.58 20.58 20.58 20.58
Reserves 86.21 107.15 118.30 142.37 160.87 -23.39 -145.66 -168.66 -183.07 -178.91 -191.63 -1.19
78.01 118.24 154.00 175.51 185.76 180.65 232.71 229.50 233.31 228.09 225.51 16.79
32.81 37.53 49.92 50.13 79.52 135.49 28.48 25.77 26.45 16.61 17.71 10.05
Total Liabilities 216.66 282.55 341.85 388.59 446.73 313.33 136.11 107.19 97.27 86.37 72.17 46.23
36.29 44.46 42.72 68.30 77.90 168.47 76.29 68.43 53.14 27.91 26.12 19.51
CWIP 30.65 40.19 68.52 107.35 112.67 0.00 0.00 0.00 0.00 0.00 0.00 0.20
Investments 2.12 10.86 13.80 13.80 13.91 0.14 10.92 0.35 0.38 0.71 0.43 0.07
147.60 187.04 216.81 199.14 242.25 144.72 48.90 38.41 43.75 57.75 45.62 26.45
Total Assets 216.66 282.55 341.85 388.59 446.73 313.33 136.11 107.19 97.27 86.37 72.17 46.23

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2025
-0.11 0.12 24.14 52.85 -9.40 107.30 25.96 1.38 4.02 -16.41 0.89 0.91
-31.99 -45.78 -42.92 -76.06 11.71 -119.90 -64.33 10.90 1.51 17.35 0.17 0.11
22.29 35.83 15.32 17.33 -7.91 15.75 35.24 -13.55 -5.30 -1.08 -1.04 0.00
Net Cash Flow -9.81 -9.83 -3.46 -5.88 -5.59 3.16 -3.13 -1.28 0.23 -0.14 0.03 1.02
Free Cash Flow -34.53 -23.28 -8.53 -13.54 -28.61 46.77 -28.42 1.26 5.52 0.82 0.89 0.91
CFO/OP 18% 16% 73% 187% -26% -233% -61% -106% -1,608% -222% -16% -228%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2025
Debtor Days 84.15 111.33 148.27 128.58 116.98 90.10 19.02 74.37 30.05 111.44 32.56
Inventory Days 168.10 170.13 156.17 148.58 99.08 109.64 7.51 37.27 31.46 17.96 39.78
Days Payable 80.64 72.62 94.42 96.33 81.02 138.60 31.59 259.10 147.68 139.44 215.28
Cash Conversion Cycle 171.62 208.84 210.02 180.82 135.04 61.14 -5.05 -147.46 -86.17 -10.05 -142.95
Working Capital Days 5.07 26.15 -9.73 -89.12 38.30 9.86 -295.95 -1,360.98 -1,002.15 -1,064.56 -3,296.44
ROCE % 19.46% 16.99% 12.12% 10.11% 14.14% -18.99% -34.48% -8.32% -8.47% 6.66% -10.53%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 May 2025
Registered Process Patents
Number

Log in to view insights

Please log in to see hidden values.

Login
Total Rated Capacity
TPA
Total Volumetric Capacity
MTPA
Actual Production Volume
MT
Capacity Utilisation
%
Number of Manufacturing Units
Number
Export Contribution to Revenue
%
Number of In-house Products
Number
Drug Master Files (DMFs) Prepared
Number
Patent Applications Pending
Number

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022
27.62% 27.62% 27.62% 27.62% 27.62% 27.62% 14.71% 27.62% 17.62% 17.62% 14.71% 14.71%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.06% 0.00% 0.01% 0.00% 0.06% 0.06%
0.01% 0.03% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.00% 0.01% 0.01% 0.01%
72.38% 72.35% 72.38% 72.38% 72.38% 72.38% 85.22% 72.38% 82.36% 82.37% 85.22% 85.22%
No. of Shareholders 19,72819,50719,08718,96518,67818,27319,43017,46119,15219,31819,43019,430

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls